机构地区:[1]漯河医学高等专科学校医疗系,漯河462002 [2]河南省特医食品工程技术研究中心,漯河462002 [3]河南省肿瘤发生与防治研究创新型科技团队,漯河462002
出 处:《世界科学技术-中医药现代化》2022年第2期723-731,共9页Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基 金:河南省高等学校重点科研项目(18A310018):石蒜碱抗肝癌Ras/raf/Mek/Erk信号通路分子机制研究,负责人:李先佳;漯河医学高等专科学校2019年度创新创业发展能力提升工程科研类项目(2020-LYZKYYB012):Twist基因沉默对人结肠癌细胞SW480生物学活性的影响,负责人:崔东涛。
摘 要:目的观察氧化槐定碱抑制HBV诱发肝纤维化的机制。方法采用细胞间非接触式的共培养体系进行培养,同时建立HBV诱发肝纤维化的动物模型,四甲基偶氮唑蓝(MTT)法检测LX-2细胞抑制率,qRT-PCR法检测α-SMA、collagenⅠmRNA水平,Western blot检测细胞纤维化、自噬、AKT/mTOR信号通路相关蛋白表达水平,运用AKT-siRNA、雷帕霉素、自噬抑制剂(3-MA)探讨自噬对肝纤维化的影响。结果体外实验显示:0.5-32 mg·L^(-1)氧化槐定碱抑制LX-2细胞的增殖(P<0.05);与对照组比较,氧化槐定碱4、8、16、32 mg·L^(-1)组α-SMA、collagenⅠmRNA表达水平降低,Beclin-1、LC3Ⅱ/LC3Ⅰ水平上调,p-AKT/AKT、p-mTOR/mTOR水平下调(P<0.05);与氧化槐定碱16 mg·L^(-1)组比较,氧化槐定碱16 mg·L^(-1)+AKT-siRNA组抑制率、LC3Ⅱ/LC3Ⅰ明显增加,p-AKT/AKT、collagenⅠ明显降低(P<0.05);与氧化槐定碱16 mg·L^(-1)组比较,氧化槐定碱16 mg·L^(-1)+3-MA组抑制率、LC3Ⅱ/LC3Ⅰ明显降低,p-AKT/AKT、collagenⅠ明显增加(P<0.05)。体内实验显示:与氧化槐定碱组比较,氧化槐定碱+雷帕霉素组ALT、AST、collagenⅠ、p-mTOR/mTOR水平明显下调,LC3Ⅱ/LC3Ⅰ水平明显上调;氧化槐定碱+3-MA组LC3Ⅱ/LC3Ⅰ水平明显下调,collagenⅠ、p-mTOR/mTOR明显上调(均P<0.05)。结论氧化槐定碱能调控肝细胞自噬,上调细胞纤维化水平,其机制可能与调控AKT/mTOR信号通路有关。Objective To observe the mechanism of oxysophoridine inhibiting HBV-induced liver fibrosis.Methods A non-contact co-cultivation system between cells was used for culture. Simultaneously, an animal model of HBVinduced liver fibrosis was established. The inhibition rate of LX-2 cells was detected by the tetramethylazazole blue(MTT) method. The levels of α-SMA and collagen Ⅰ mRNA were detected by qRT-PCR, Protein expression levels of cell fibrosis, autophagy, and AKT/mTOR signaling pathway was detected by Western blot. And AKT-siRNA, rapamycin and autophagy inhibitor(3-MA) was used to explore the effect of autophagy on liver fibrosis.Results In vitro experiments showed 0.5-32 mg·L^(-1)oxysophoridine inhibited the proliferation of LX-2 cells(P<0.05). Compared with the control group, the expression level of α-SMA and collagen Ⅰ mRNA decreased, the levels of Beclin-1, LC3 Ⅱ/LC3 Ⅰ were upregulated, and the levels of p-AKT/AKT, p-mTOR/mTOR were down-regulated in oxysophoridine 4, 8, 16, 32 mg·L^(-1)groups(P<0.05). Compared with oxysophoridine 16 mg·L^(-1)group, the inhibition rate and LC3 Ⅱ/LC3 Ⅰ was significantly increased, and collagen Ⅰ,p-AKT/AKT was significantly decreased in oxysophoridine 16 mg·L^(-1)+AKT-siRNA group(P<0.05). Compared with oxysophoridine 16 mg·L^(-1)group, the inhibition rate and LC3 Ⅱ/LC3 Ⅰ decreased significantly, and collagen Ⅰ and p-AKT/AKT increased significantly in oxysophoridine 16 mg·L^(-1)+3-MA group(P<0.05). Compared with the oxysophoridine group, the ALT, AST, collagen Ⅰ, and p-mTOR/mTOR levels in the oxysophoridine + rapamycin group were significantly down-regulated, and the LC3 Ⅱ/LC3 Ⅰ levels were significantly up-regulated. The levels of LC3 Ⅱ/LC3 Ⅰ in the oxysophoridine +3-MA group were significantly down-regulated, and collagen Ⅰ and p-mTOR/mTOR were significantly up-regulated in vivo experiments(all P<0.05).Conclusion Oxysophoridine can regulate hepatocyte autophagy and down-regulate the level of cell fibrosis. The mechanism may be related to
关 键 词:氧化槐定碱 AKT/mTOR通路 自噬 HBV 肝纤维化
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...